Clinical Research Core
Clinical Research Core
批准号:
8738917
负责人:
GLORIA M. PETERSEN
金额:
$24.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-18 至 2019-08-31
关键词:
AdherenceAgeBiostatistics CoreCancer CenterCancer PatientClinicClinical ResearchClinical TrialsCommunitiesConsentDataData CollectionDatabasesDevelopmentDiagnosisEnsureFundingFutureGoalsHumanK-Series Research Career ProgramsMalignant NeoplasmsMalignant neoplasm of pancreasMethodsObservational StudyPancreatic AdenocarcinomaPatient RecruitmentsPhasePoliciesProgram Research Project GrantsProtocols documentationRaceRecruitment ActivityRegistriesRegulationResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesSystemTissuesTranslational Researchcase findingexperiencefollow-uphigh standardhuman subjectpatient populationpatient registrysex
中文摘要
临床研究核心将正在进行的患者登记活动与新的临床试验相结合
在拟议的资助期内,所有四个转化研究项目的活动。临床的目的
研究核心是:1)执行必要的临床试验管理支持活动; 2)集中
与癌症中心CRO的基础设施协调所有活动,以确保
SPORE的早期临床试验; 3)执行临床试验的所有患者招募活动,
(4)维持胰腺癌患者的超快速病例招募和登记;以及
6)作为未来发展研究计划和职业发展计划的资源
研究项目。该中心的主任在人类受试者研究方面具有丰富的经验,
招募患者参与研究方案,包括观察性研究和临床试验。马约诊所
诊断和/或治疗估计650胰腺癌患者,每年在其三个校区。到
迄今为止,胰腺癌SPORE的患者登记活动非常富有成效,
5,395名受试者同意,使用超快速病例发现,这是这种快速致命癌症的必要方法。
登记研究中有3,121例胰腺癌患者。此外,书记官处
包括2,500多名年龄、性别、种族和地区匹配的健康对照者的数据。它将协调其
活动与生物统计学核心和组织核心非常密切,以确保注释的最高质量
生物标本和胰腺癌数据库进行研究。密切协调和监督
SPORE的大多数高级领导人将确保所有临床研究活动都是在
最高水平的研究诚信和遵守所有人类受试者法规。
英文摘要
The Clinical Research Core combines the ongoing Patient Registry activities with the new clinical trial
activities in all four translational research projects in the proposed funding period. The aims of the Clinical
Research Core are to: 1) perform the necessary clinical trial management support activities; 2) centrally
coordinate all activities with the infrastructure of the Cancer Center CRO to ensure smooth execution of the
SPORE¿s early-phase clinical trials; 3) perform all patient recruitment activities for the clinical trials in the
SPORE projects; 4) maintain the ultra-rapid case recruitment and registry of pancreatic cancer patients; and
6) serve as a resource to future Developmental Research Program and Career Developmental Program
research projects. The directors of this Core have extensive experience in studies of human subjects and
recruitment of patients to research protocols, both for observational studies and clinical trials. Mayo Clinic
diagnoses and/or treats an estimated 650 pancreatic cancer patients per year across its three campuses. To
date, the pancreatic cancer SPORE¿s Patient Registry activities have been very productive, with accrual of
5,395 consented subjects, using ultra-rapid case finding, a necessary method for this rapidly fatal cancer.
There are 3,121 pancreatic adenocarcinoma cancer patients in the Registry. In addition, the Registry
includes data on over 2,500 age, sex, race, and region-matched healthy controls. It will coordinate its
activities very closely with the Biostatistics Core and the Tissue Core to ensure the highest quality annotated
biospecimens and pancreatic cancer database for research. The close coordination and oversight of the
most senior leaders of the SPORE will ensure that all clinical research activities are performed with the
highest level of research integrity and adherence to all human subjects regulations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
-
批准号:10471570
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2021
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
-
批准号:10427575
-
项目类别:
-
资助金额:$81.13万
-
财政年份:2016
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
-
批准号:9768973
-
项目类别:
-
资助金额:$86.88万
-
财政年份:2016
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
-
批准号:9352900
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2016
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
-
批准号:9316574
-
项目类别:
-
资助金额:$89.8万
-
财政年份:2016
-
负责人:GLORIA M. PETERSEN
-
依托单位:
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
-
批准号:10684464
-
项目类别:
-
资助金额:$8.54万
-
财政年份:2015
-
负责人:GLORIA M. PETERSEN
-
依托单位:
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
-
批准号:10254446
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2015
-
负责人:GLORIA M. PETERSEN
-
依托单位:
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
-
批准号:10263461
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2015
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Administrative Core
-
批准号:8738915
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2014
-
负责人:GLORIA M. PETERSEN
-
依托单位:
CA: Administrative Core
-
批准号:8719567
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2013
-
负责人:GLORIA M. PETERSEN
-
依托单位:
CC: Clinical Research
-
批准号:8719569
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2013
-
负责人:GLORIA M. PETERSEN
-
依托单位:
CC: Clinical Research
-
批准号:7510973
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2008
-
负责人:GLORIA M. PETERSEN
-
依托单位:
CA: Administrative Core
-
批准号:7510969
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2008
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:7279142
-
项目类别:
-
资助金额:$217.95万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:7504834
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:6804600
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:8316352
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:6950423
-
项目类别:
-
资助金额:$229.87万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:8719559
-
项目类别:
-
资助金额:$123.33万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:7125096
-
项目类别:
-
资助金额:$224.46万
-
财政年份:2003
-
负责人:GLORIA M. PETERSEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: